Shares of Pacific Biosciences of California slid by a staggering 41.04% in 30 days from $43.18 to $25.46 at 20:46 EST on Tuesday, after five sequential sessions in a row of losses. NASDAQ Composite is falling 1.88% to $13,633.50, after three consecutive sessions in a row of losses.

Pacific Biosciences of California’s last close was $27.27, 110.88% below its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 74.4% for the present quarter and 71.5% for the next. The company’s growth estimates for the present quarter and the next is a negative 40% and a negative 57.1%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $25.46 at 20:46 EST, way below its 52-week high of $53.69 and way higher than its 52-week low of $2.66.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is way under its 50-day moving average of $33.94 and higher than its 200-day moving average of $24.72.

More news about Pacific Biosciences of California.

LEAVE A REPLY

Please enter your comment!
Please enter your name here